Rentschler Biotechnologie GmbH Company Profile

06:20 EDT 24th March 2018 | BioPortfolio

Rentschler Biotechnologie GmbH, Laupheim (Germany), is an international full-service contract manufacturer with more than 30 years of experience in the development, production and approval of biopharmaceuticals in compliance with international GMP standards. In addition, Rentschler provides regulatory advice and fill and finish services. As a pioneer in the development and production of biopharmaceuticals, Rentschler was the first company in the world to gain market authorization for an interferon-containing drug. In 2006, Rentschler announced an investment program of €50 million for expansion of production systems. Capacities up to 2,500 L in owned facilities and a trusted preferred partnership agreement with Boehringer Ingelheim for a seamless project transfer to large-scale manufacturing of up to 15,000 L assure development and planning security throughout the whole development process - from clinical phases up to the market production. Our experience with international regulatory affairs and authorities speeds up the time to market and ensures the market success of your product..

Full services from one source for over 30 years

Rentschler Biotechnologie offers all services from one source and is therefore able to react with maximal flexibility to customers’ needs and requirements for rapid and reliable project success. Short development periods, optimal time to market and the highest standards of quality and efficiency are guaranteed.

GMP certified services:

• Cell Line and Process Development

• Production of Active Pharmaceutical Ingredients (API)

• Fill and Finish

• Analytics and Quality Control

• Regulatory Affairs

• Quality Assurance

• Corporate Project Management


Erwin-Rentschler-Straße 21


Phone: +49 (0) 7392 701-555
Fax: +49 (0) 7392 701-521

News Articles [162 Associated News Articles listed on BioPortfolio]

Dr. Rentschler Holding and Rentschler Biopharma choose prevero's BI solution

prevero, a unit4 company and software provider for Business Intelligence and Corporate Performance Management solutions, has been selected by the global biopharmaceutical manufacturer Rentschler Bioph...

Rentschler Biotechnologie GmbH Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28112017] Prices from USD $250

SummaryRentschler Biotechnologie GmbH Rentschler, a subsidiary of Dr. Rentschler Holding GmbH Co KG is a contract development and manufacturing organization that develops and manufactures biopharmace...

BRAIN AG: Deutscher Biotech-Gesellschaft gelingt rascher Fortschritt in hochinteressantem Markt

Der Bereich der sogenannten weißen Biotechnologie, auch industrielle Biotechnologie genannt, gewinnt immer mehr an Bedeutung. Ihr werden enorme Wachstumsraten vorausgesagt. Ein bekannter Anwendungs.....

Rentschler Biopharma & Leukocare report success of strategic alliance

Rentschler Biopharma and Leukocare have reported the success of the first year of their strategic alliance, incorporating formulation development in each step of the biopharmaceutical development and ...

Rentschler Biopharma SE Appoints International Biopharma Expert Dr. Ralf Otto as Chief Operating Officer

Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, today appointed Dr. Ralf Otto (46) as Chief Operating Officer...

Rentschler Biopharma Appoints COO

Dr. Ralf Otto has over two decades industry experience

Rentschler Biopharma Appoints SVP

Federico Pollano comes with over two decades of experience, and will head the business development unit

Rentschler Biopharma and Leukocare Demonstrate Success of Strategic Alliance for Biopharmaceutical Development and Formulation

Rentschler Biopharma and Leukocare demonstrate success of strategic alliance for biopharmaceutical development and formulation - First year of alliance delivers project w...

Drugs and Medications [26 Associated Drugs and Medications listed on BioPortfolio]

Alcohol prep pad [Büttner-Frank GmbH]

Firmagon [Ferring Pharmaceuticals Inc.]

These highlights do not include all the information needed to use FIRMAGON safely and effectively. See full prescribing information for FIRMAGON. FIRMAGON® (degarelix for injection) for subcutaneous ...

La prairie switzerland [Juvena Produits de Beaute GMBH]

Package.Label Principle Display Panel

Purax pure pads [Purax International GmbH]

PURAX Pure Pads Anti-Perspirant Spray

Ultra protection stick [Juvena Produits De Beaute GMBH]

Ultra Protection stick SPF 40

PubMed Articles [14 Associated PubMed Articles listed on BioPortfolio]

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results.

Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in the trabecular meshwork (iStent®, iStent I...

Postoperative Corneal Asphericity in Low, Moderate, and High Myopic Eyes After Transepithelial PRK Using a New Pulse Allocation.

To evaluate the postoperative asphericity in low, moderate, and high myopic eyes after combined transepithelial photorefractive keratectomy and SmartSurfACE treatment (SCHWIND eye-tech-solutions GmbH,...

Reliability of a Skin Diagnostic Device in Assessing Hydration and Erythema.

To examine the reliability of a skin diagnostic device, the SD202 (Courage+Khazaka GmBH, Cologne, Germany), in assessing hydration and erythema of periwound skin and pressure injury-prone areas.

Clinical Trials [42 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Telemedical Examination of a Three-Component Oculomotor Testing Battery

The study investigates the feasibility and safety of the telemedical implementation of three diagnostic oculomotor tests using a video-oculography device and an extended teleconferencing s...

Companies [542 Associated Companies listed on BioPortfolio]

Rentschler Biotechnologie GmbH

Rentschler Biotechnologie GmbH, Laupheim (Germany), is an international full-service contract manufacturer with more than 30 years of experience in the development, production and approval of biopharm...

Rentschler Biopharma SE

Rentschler Biopharma SE, located in Laupheim, Germany, is a leading contract development and manufacturing organization (CDMO) for bioprocess development and manufacturing of biop...


BIOTECHNOLOGIE KEMPE GMBH has been located in Berlin for more than twenty years (since 2004 on the outskirts of the city). We focus on development and construction of measuring and control equipment f...

Jennewein Biotechnologie GmbH

Cephalon GmbH

Für die Betreuung der Märkte in Deutschland, Österreich und der Schweiz wurde 1997 in München die Cephalon GmbH gegründet. Im Jahr 2002 erfolgte der Umzug nach Martinsried bei München, einem der...

More Information about "Rentschler Biotechnologie GmbH" on BioPortfolio

We have published hundreds of Rentschler Biotechnologie GmbH news stories on BioPortfolio along with dozens of Rentschler Biotechnologie GmbH Clinical Trials and PubMed Articles about Rentschler Biotechnologie GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Rentschler Biotechnologie GmbH Companies in our database. You can also find out about relevant Rentschler Biotechnologie GmbH Drugs and Medications on this site too.

Quick Search


Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Corporate Database Quicklinks

Searches Linking to this Company Record